Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer.
暂无分享，去创建一个
O. Lambotte | A. Hollebecque | S. Champiat | A. Marabelle | C. Massard | A. Varga | J. Michot | J. Le Pavec | A. Laparra | M. Collins | A. Vozy | A. Voisin | A. Simonaggio | A. Lallart | G. Cengizalp | Ariane Laparra | J. Le Pavec